Skip to main content
. 2020 Aug 28;11:4328. doi: 10.1038/s41467-020-18167-4

Fig. 3. Ketamine and Cav1.2 agonist Bay k8644 are mutual antagonists.

Fig. 3

a Representative traces of Bay k8644-mediated potentiation of EFS-stimulated BSM contraction, summarized in d (n = 7 BSM strips). b Representative traces of Bay k8644-mediated potentiation of EFS-stimulated BSM contraction fully inhibited by ketamine and by nifedipine in dose-dependent manners, summarized in e (n = 8 BSM strips) and f (n = 12 BSM strips). c representative traces of ketamine-induced and nifedipine-induced inhibition of EFS-stimulated BSM contraction rescued by 50 or 200 nM Bay k8644, summarized in g (n = 17 BSM strips) and h (n = 13 BSM strips). Data are presented as mean values ± SD. These data support ketamine as an inhibitor of Cav1.2-mediated BSM contraction. Source data are provided as a Source Data file.